CD8A and neoplasm: However, the BAFF/APRIL system can also act as an inhibitor of tumor infiltrating CD8+ T cells, inhibited by regulatory B cells (Bregs), and a pro-oncogenic factor in some tumors, complicating its role in tumor progression 145, 148.